Skip to main content
TipRanks
Go Ultimate75% OFF

Takeda Pharmaceutical Company (TAKN) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

TAKN Analyst Ratings

Moderate Buy
1Ratings
1Buy0Hold0Sell
Based on 1 analysts giving stock ratings to Takeda Pharmaceutical Company in the past 3 months

TAKN Stock 12 Month Forecast

Mex$799.04▲(131.61% Upside)
Based on 1 Wall Street analysts offering 12 month price targets for Takeda Pharmaceutical Company in the last 3 months. The average price target is MXN 799.04 with a high forecast of MXN 799.04 and a low forecast of MXN 799.04. The average price target represents a 131.61% change from the last price of MXN 345.00.
Highest Price TargetMex$799.04Average Price TargetMex$799.04Lowest Price TargetMex$799.04

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for MX:TAKN
Price TargetArticle
Bank of America SecuritiesMex$799.04buy131.61%UpsideReiterated09/14/26
TD CowenMex$391.13buy13.37%UpsideReiterated06/04/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
DFTXDefinium Therapeutics
RDNTRadnet
AXGNAxoGen
PLSEPulse Biosciences
AHCOAdaptHealth

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Takeda Pharmaceutical Company

3 Months
Koichi Mamegano
Koichi MameganoBank of America Securities
Success Rate4/7 ratings generated profit
57%
Average Return
+7.19%

Copying Koichi Mamegano's trades and holding each position for 3 Months would result in 57.14% of your transactions generating a profit, with an average return of +7.19% per trade.

1 Year
Success Rate9/12 ratings generated profit
75%
Average Return
+15.32%

Copying Michael Nedelcovych's trades and holding each position for 1 Year would result in 75.00% of your transactions generating a profit, with an average return of +15.32% per trade.

2 Years
Success Rate12/12 ratings generated profit
100%
Average Return
+35.58%

Copying Michael Nedelcovych's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +35.58% per trade.

TAKN Analyst Recommendation Trends

01234Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for TAKN
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy01221
Buy23210
Hold00000
Sell00000
Strong Sell00000
total24431

In the current month, TAKN has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. TAKN average Analyst price target in the past 3 months is 799.04.

TAKN Financial Forecast

Mex$-2Mex$0.5Mex$3Mex$5.5Mex$8Q4 2025Q2 2026Q3 2026
HighMex$2.86
ConsensusMex$2.64
LowMex$2.40

TAKN Earnings Forecast

Next quarter’s earnings estimate for TAKN is MXN 2.64 with a range of MXN 2.40 to MXN 2.86. The previous quarter’s EPS was MXN 7.14. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

Mex$126.3BMex$131.5BMex$136.7BMex$142BMex$147.2BQ4 2025Q2 2026Q3 2026
HighMex$147B
ConsensusMex$139B
LowMex$126B

TAKN Sales Forecast

Next quarter’s sales forecast for TAKN is MXN 139.15B with a range of MXN 126.27B to MXN 147.18B. The previous quarter’s sales results were MXN 138.57B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

TAKN Stock Forecast FAQ

What is MX:TAKN’s average 12-month price target, according to analysts?
Based on analyst ratings, Takeda Pharmaceutical Company’s 12-month average price target is Mex$799.04.
What is MX:TAKN’s upside potential, based on the analysts’ average price target?
Takeda Pharmaceutical Company has 131.61% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Takeda Pharmaceutical Company a Buy, Sell or Hold?
Takeda Pharmaceutical Company has a consensus rating of Moderate Buy, which is based on 1 buy ratings, 0 hold ratings and 0 sell ratings.
What is Takeda Pharmaceutical Company’s share price target?
The average share price target for Takeda Pharmaceutical Company is Mex$799.04. This is based on 1 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$799.04, and the lowest forecast is Mex$799.04. The average share price target represents a 131.61% increase from the current price of Mex$345.
What do analysts say about Takeda Pharmaceutical Company?
Takeda Pharmaceutical Company’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 1 Wall Street analysts.
How can I buy shares of Takeda Pharmaceutical Company?
To buy shares of MX:TAKN, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.